The Tohoku Journal of Experimental Medicine 2010-05-01

Fanconi anemia is characterized by delayed repair kinetics of DNA double-strand breaks.

Andreja Leskovac, Dragana Vujic, Marija Guc-Scekic, Sandra Petrovic, Ivana Joksic, Predrag Slijepcevic, Gordana Joksic

Index: Tohoku J. Exp. Med. 221(1) , 69-76, (2010)

Full Text: HTML

Abstract

Among patients with bone marrow failure (BMF) syndrome, some are happened to have underlying Fanconi anemia (FA), a genetically heterogeneous disease, which is characterized by progressive pancytopenia and cancer susceptibility. Due to heterogeneous nature of the disease, a single genetic test, as in vitro response to DNA cross-linking agents, usually is not enough to make correct diagnosis. The aim of this study was to evaluate whether measuring repair kinetics of radiation-induced DNA double-strand breaks (DSBs) can distinguish Fanconi anemia from other BMF patients. An early step in repair of DSBs is phosphorylation of the histone H2AX, generating gamma-H2AX histone, which extends over mega base-pair regions of DNA from the break site and is visualised as foci (gamma-H2AX foci) with specific antibodies. The primary fibroblasts, established from FA patients, were exposed to gamma-rays, a dose of 2 Gy ((60)Co), incubated for up to 24 hours under repair-permissive conditions, and assayed for the level of gamma-H2AX foci and apoptosis at different recovery times after the treatment. Cell lines originating from FA patients displayed a significant delay in the repair of radiation-induced DNA DSBs relative to non-FA bone marrow failure (non-FA BMF) and control cell lines. The delay is especially evident at recovery time of 24 hours, and is seen as about 8-fold increase of residual gamma-H2AX foci compared to self-state before irradiation. The delay in repair kinetics of FA cells represents the unique feature of FA cellular phenotype, which should be exploited to distinguish FA cellular phenotype.


Related Compounds

  • 2,2′-bioxirane

Related Articles:

Modelling Fanconi anemia pathogenesis and therapeutics using integration-free patient-derived iPSCs.

2014-01-01

[Nat. Commun. 5 , 4330, (2014)]

DNA damage induced by three major metabolites of 1,3-butadiene in human hepatocyte L02 cells.

2012-09-18

[Mutat. Res. 747(2) , 240-5, (2012)]

Alkyltransferase-mediated toxicity of bis-electrophiles in mammalian cells.

2010-02-03

[Mutat. Res. 684(1-2) , 35-42, (2010)]

Protective effect of acetyl-l-carnitine and α-lipoic acid against the acute toxicity of diepoxybutane to human lymphocytes.

2011-10-28

[Toxicology 289(1) , 52-8, (2011)]

1,2:3,4-Diepoxybutane in blood of male B6C3F1 mice and male Sprague-Dawley rats exposed to 1,3-butadiene.

2011-12-15

[Toxicol. Lett. 207(3) , 286-90, (2011)]

More Articles...